Crossmark

Standalone XEN45 Gel Stent implantation versus combined XEN45-phacoemulsification in the treatment of open angle glaucoma—a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s00417-021-05189-x

Published Online: 2021-04-29

Published Print: 2021-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lim, Sheng Yang https://orcid.org/0000-0002-4463-4932
Betzler, Bjorn Kaijun

Yip, Leonard Wei Leon

Dorairaj, Syril

Ang, Bryan Chin Hou
License Information

Text and Data Mining valid from 2021-04-29

Version of Record valid from 2021-04-29
More Information

Article History

Received: 23 January 2021

Revised: 19 March 2021

Accepted: 7 April 2021

First Online: 29 April 2021

Declarations

:

: The authors alone are responsible for the content and writing of the paper.

: SYL and BKB report no conflicts of interest, financial or propriety, in the subject matter or materials discussed in this manuscript. LWLY is a consultant for Allergan plc and has received previous funding from Allergan for travel and research. However, he has not received funding for his work in this publication. SD is a consultant for New World Medical, Inc, Iridex Corporation and Santen Pharmaceutical Co., Ltd and has received previous funding for travel and research. He has not received funding for his work in this publication. BCHA has received previous funding from Allergan plc for travel and research. However, he has not received funding for his work in this publication.

Document is current

Any future updates will be listed below